The Leaders Globe Media

A study from Michigan State University and Stanford University suggest, the nano-sized cells that transfer genetic material to other cells in our body may turn into mini treatment transporters to kill cancer cells. The study published in the journal, ‘Molecular Cancer Therapeutics’ focused on breast cancer cells in mice. Masamitsu Kanada, lead author and an assistant professor of pharmacology and toxicology in MSU’s Institute for Quantitative  Health  Science and Engineering said, “What we’ve done is improve a therapeutic approach to delivering enzyme-producing genes that can convert certain drugs into toxic agents and target tumours,” These drugs, or pro-drugs, start out as inactive compounds. But once they metabolise in the body, they’re immediately activated and can get to work on fighting everything from cancer to headaches. Aspirin is an example of a common pro-drug. In this case, researchers used extracellular vesicles, or EVs, to deliver the enzyme-producing gen...